Advanced Flower Capital Inc. (AFCG) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call presents a mixed picture: strong net investment income and NAV growth are positive, but operational risks in Justice Grown and unclear guidance on asset deployment create uncertainty. Share buyback and dividend announcements offer some support, but litigation and non-operational assets could dampen enthusiasm. With no strong positive or negative catalysts, and given the lack of market cap data, the stock is likely to remain stable in the short term.
Key Financial Performance
Net Investment Income $4.8 million or $0.21 per basic weighted average share of common stock for Q1 2026. This represents an increase in net asset value per share by $0.44 over the prior quarter, driven by net investment income of $0.21 per share and an increase in unrealized appreciation on investments of approximately $0.28 per share, offset by the Q1 dividend of $0.05 per share.
Total Investment Income $9.8 million for Q1 2026. No specific year-over-year change or reasons for change were mentioned.
Principal Outstanding $356.6 million spread across 15 loans as of March 31, 2026, and $370 million across 17 loans as of May 1, 2026. No specific year-over-year change or reasons for change were mentioned.
Total Assets $394.9 million as of March 31, 2026. No specific year-over-year change or reasons for change were mentioned.
Total Shareholder Equity $185.8 million as of March 31, 2026. No specific year-over-year change or reasons for change were mentioned.
Net Asset Value (NAV) Per Share $7.90 as of March 31, 2026, an increase of $0.44 per share over the prior quarter. The increase was driven by net investment income of $0.21 per share, an increase in unrealized appreciation on investments of approximately $0.28 per share, offset by the Q1 dividend of $0.05 per share.
Senior Secured Revolving Credit Facility Expanded to $80 million during Q1 2026, with an additional $30 million commitment from the facility's lead arranger. The facility remains available to $100 million subject to lender participation in the borrowing base. No specific year-over-year change or reasons for change were mentioned.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
BDC Conversion: AFC completed its first quarter operating as a Business Development Company (BDC), which has expanded its investment flexibility beyond real estate-backed loans.
Non-Cannabis Deals: Closed 2 non-cannabis deals in the lower middle market, totaling approximately $90 million in new commitments.
Lower Middle Market Expansion: AFC is actively expanding its pipeline in the lower middle market, focusing on cash-flowing businesses with $5 million to $50 million EBITDA. The pipeline includes over $1.5 billion of deals across industries like healthcare, consumer, manufacturing, and services.
Loan Repayments: Received $41.2 million in cannabis loan repayments during Q1 2026.
Share Buyback Program: The Board of Directors authorized a $5 million share buyback program to enhance long-term shareholder value.
Credit Facility Expansion: Expanded senior secured revolving credit facility to $80 million, with an additional $30 million commitment from the lead arranger.
Portfolio Diversification: Strategically diversifying portfolio by expanding into private credit outside of the cannabis space and targeting lower middle market opportunities.
Justice Grown Loan Default: The loan to Justice Grown matured on May 1, 2026, and is in maturity default. AFC plans to exercise its rights under the credit agreement to realize maximum value.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Cannabis Loan Defaults: Three loans are on nonaccrual status, including Justice Grown, which is in maturity default. The company is pursuing remedies under the credit agreement to recover value, but these defaults represent a risk to income and capital recovery.
Portfolio Diversification Risks: While expanding into non-cannabis private credit, the company is entering new industries such as healthcare, consumer, and manufacturing. This diversification could expose AFC to risks outside its core competencies.
Economic and Market Conditions: The lower middle market is experiencing reduced capital inflows and increased competition, which could impact AFC's ability to secure favorable deals and maintain high returns.
Credit Quality and Covenant Risks: The company is underwriting deals with stricter covenants compared to larger markets, but there is still a risk of credit quality deterioration in the lower middle market.
Operational Risks in Justice Grown Assets: Justice Grown's assets in New Jersey and Pennsylvania, including cultivation facilities and dispensaries, are partially non-operational, which could hinder recovery efforts and asset valuation.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Expansion into private credit outside of cannabis: The company is actively expanding its pipeline and diversifying its portfolio into private credit outside of the cannabis space. The active pipeline remains strong with over $1.5 billion of deals as of today, focusing on lower middle market lending across industries such as healthcare, consumer, manufacturing, and services.
Target market and deal characteristics: The company is targeting cash-flowing borrowers with $5 million to $50 million of EBITDA, primarily in sponsored transactions but selectively engaging in non-sponsor deals. Financing is focused on expansion capital, acquisitions, refinancings, or recapitalizations.
Recent and future loan activity: During Q1 2026, AFC closed 2 loans totaling $90 million and subsequently closed an additional $5 million of loans. The company plans to redeploy capital from non-performing loans into performing credits to enhance current income.
Market opportunity in lower middle market: The company sees a compelling opportunity in the lower middle market due to reduced competition and better risk-adjusted returns, with absolute yields running approximately 100 to 300 basis points higher than six months ago.
Capital allocation strategy: The Board of Directors has authorized a $5 million share buyback program as part of its capital allocation strategy to enhance long-term shareholder value.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
First Quarter Distribution: The Board of Directors declared a first quarter distribution of $0.05 per share, which was paid on April 15, 2026, to shareholders of record on March 31, 2026.
Share Buyback Program: The Board of Directors has put a $5 million share buyback program in place as a flexible component of the capital allocation strategy, designed to enhance long-term shareholder value.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:How should we think about potential outcomes regarding Justice Grown given the other litigation that is pending and the loan being in default?
A:The loan has matured, and the company is pursuing all rights and remedies to obtain maximum value from the credit facility. However, it is too early to predict outcomes in the litigation.
Q:Are there still questions around being able to fully take over Justice Grown given the other litigation pending?
A:The company is pursuing strategies to obtain maximum value from the collateral.
Q:What are the expected yields for incremental loans in the pipeline?
A:The yields are expected to move down slightly into the low double-digit range overall, with improved quality of borrowers and counterparties in the lower middle market.
Q:Does the recent rescheduling of cannabis change the outlook for the cannabis market or the company's focus?
A:The rescheduling is seen as progress at the federal level, potentially eliminating 280E liabilities for medical operators and attracting additional capital. However, the company remains focused on expanding into lower middle market lending, which offers better opportunities and less competition.
Q:Can you provide more details about the two large loans made in the first quarter to non-cannabis companies?
A:The first loan was to STAT, a company operating in the revenue recovery space for suppliers to large retailers like Walmart and Target. The proceeds were used for refinancing an existing credit facility and partially financing the acquisition of the Moresby Group. The second loan was to BCIS, a healthcare benefits platform for low-wage employees, offering low-cost options for virtual urgent care, primary care, and generic prescriptions. The platform is experiencing significant growth.
Q:Can the company deploy all the cash on the balance sheet and the expanded credit facility this year?
A:It is hard to predict or provide guidance on funding for the rest of the year, but the company has dry powder to deploy and will look to reinvest repayments received during the year.
Q:Review of Unclear Management Responses
A:Management avoided giving a direct answer to the question about fully taking over Justice Grown, as they only stated they are pursuing strategies to obtain maximum value from the collateral without addressing the specifics of the litigation or takeover process. Additionally, they did not provide clear guidance on the deployment of cash and credit facility for the rest of the year, citing unpredictability in the lower middle market.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AFC Instructions
AFC funding
AFC investment
AFC loan
Capital AFC
Chairman Chief
Directors distribution
Directors share
Grown asset
Holdings paydown
Instructions Chief
Lenders liquidity
Officer Chairman
Robyn credit
acquisition
agreement right
agreement value
cash flow
commitment
covenant
credit agreement
cultivation facility
deal
expansion
guarantee
health care
lender
paydowns
platform
reduction
remedy credit
right remedy
risk
share buyback
spot
state
upmarket
vintage
AFCG Transcript
Advanced Flower Capital Inc. (AFCG) Q1 2026 Earnings Call Transcript
Unknown5-7
The earnings call presents a mixed picture: strong net investment income and NAV growth are positive, but operational risks in Justice Grown and unclear guidance on asset deployment create uncertainty. Share buyback and dividend announcements offer some support, but litigation and non-operational assets could dampen enthusiasm. With no strong positive or negative catalysts, and given the lack of market cap data, the stock is likely to remain stable in the short term.
Advanced Flower Capital Inc. (AFCG) Q4 2025 Earnings Call Transcript
Unknown3-4
The company's earnings call reveals several negative indicators: realized losses impacting earnings, a significant CECL reserve indicating expected credit losses, and a negative distributable earnings per share for the quarter. Despite an expanded investment mandate and a growing pipeline, there is uncertainty about sustaining loan originations and reluctance to invest in cannabis due to regulatory issues. The lack of guidance on certain questions during the Q&A further adds to uncertainty. These factors suggest a negative sentiment, likely leading to a stock price decline of -2% to -8%.
Advanced Flower Capital Inc. (AFCG) Q3 2025 Earnings Call Transcript
Unknown11-12
The earnings call reveals a mix of financial challenges, such as GAAP net loss and decreased distributable earnings, alongside strategic shifts like the BDC conversion. However, the lack of clear guidance on dividends and deployment, coupled with management's evasive responses, suggests uncertainty. The potential positive impact of diversification and capital returns is overshadowed by immediate financial underperformance and unclear future plans, leading to a negative sentiment.
Advanced Flower Capital Inc. (AFCG) Q2 2025 Earnings Call Transcript
Unknown8-14
The earnings call reveals several negative factors: a GAAP net loss, increased CECL reserves, unrealized losses, and no year-over-year improvements in key financial metrics. The Q&A section highlights uncertainties regarding the BDC conversion's impact on investment opportunities and credit facilities, coupled with a lack of clarity on future portfolio composition. Despite some optimism about rescheduling cannabis, the overall sentiment is cautious. Given these factors, the stock is likely to experience a negative reaction, with a potential decline in the -2% to -8% range.
AFCG Slides
AFCG Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
